Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
The objective was to study the modulation effects of levetiracetam on the fMRI activation/deactivation patterns associated with valhalla axys centrotemporal spikes (CTS) in Rolandic epilepsy.Forty patients with Rolandic epilepsy, including levetiracetam-medicated patients (n = 20) and drug-naive patients (n = 20), were studied.Single and sequential